Analyst Online UK

This systematic review and meta-analysis evaluates the efficacy and safety of pharmacological treatments for obesity, focusing on obesity management medications (OMMs) like orlistat, semaglutide, and tirzepatide. The study analyzed 56 clinical trials involving over 60,000 patients, demonstrating that all OMMs significantly reduced total body weight loss compared to placebo, particularly semaglutide and tirzepatide which achieved over 10% weight loss. The analysis also highlighted improvements in obesity-related complications and metabolic parameters, emphasizing the need for individualized treatment strategies for obesity management.

This systematic review and meta-analysis evaluates the efficacy and safety of pharmacological treatments for obesity, focusing on obesity management medications (OMMs) like orlistat, semaglutide, and tirzepatide. The study analyzed 56 clinical trials involving over 60,000 patients, demonstrating that all OMMs significantly reduced total body weight loss compared to placebo, particularly semaglutide and tirzepatide which achieved over 10% weight loss. The analysis also highlighted improvements in obesity-related complications and metabolic parameters, emphasizing the need for individualized treatment strategies for obesity management.